Abstract:The present paper builds upon previous work on mAb domain contributions to multimodal (MM) chromatography by examining how pH can impact mAb surface properties and retention in these systems. Linear salt gradient experiments were carried out between pH 5-7 for several mAbs with different pI and surface hydrophobicities in four different MM CEX resins at two ligand densities. mAb retention showed an inverse, non-linear correlation with pH. Changing pH affected the elution order, creating unique windows of selectivity in each of the MM CEX resins. One mAb showed a pH-dependent spectrum of domain contributions, demonstrating that pH can be used to tune the relative importance of the (Fab)2 and Fc domains for some mAbs in MM systems. Positive, negative, and hydrophobic patches were calculated between pH 5-7 for the mAbs. Visualizing these patches on the protein surface demonstrated that each mAb showed a unique distribution of surface charge and hydrophobicity that changed with pH. The sum of patch areas was tracked across this pH range to quantitatively understand how pH impacted these important surface properties. The quantitative analysis then was narrowed to consider only patches in the CDR loops, which were hypothesized to be an important interaction site for some mAbs in these systems. Interestingly, differences in the titration of CDR loop patches for each mAb were shown to be a result of Histidine titrations and patches in this region were qualitatively correlated with experimental trends including the observed elution order reversals. These results indicate that pH potentially can be employed as a lever for the strategic design of multimodal steps to create flow through, bind and elute, or weak partitioning operations with important implications for the design of integrated and/or continuous downstream purification processes. Furthermore, the ability to tune domain contributions in MM separations using pH creates intriguing possibilities for current downstream challenges such as the removal of product-related impurities, as well as the purification of bispecific mAbs.

Enhancing Selectivity of Protein Biopharmaceuticals in Ion Exchange Chromatography through Addition of Organic Modifiers

Separation of Monoclonal Antibody Charge Variants Using Cation Exchange Chromatography: Resins and Separation Conditions Optimization

A Novel Twin‐column Continuous Chromatography Approach for Separation and Enrichment of Monoclonal Antibody Charge Variants

Binary Adsorption Processes of Albumin and Immunoglobulin on Hydrophobic Charge-Induction Resins

Binding Mechanism of Functional Moieties of a Mixed-Mode Ligand in Antibody Purification

Development of a Hybrid Biomimetic Ligand with High Selectivity and Mild Elution for Antibody Purification

Study on Antibody Adsorption and Elution Performance of Carboxyl and Hydrophobic Groups on Mixed-Mode Ligands

Tuning selectivity in cation-exchange chromatography applied for monoclonal antibody separations, part 1: Alternative mobile phases and fine tuning of the separation

Modeling the impact of amino acid substitution in a monoclonal antibody on cation exchange chromatography

Coupling Anion Exchange Chromatography with Native Mass Spectrometry for Charge Heterogeneity Characterization of Monoclonal Antibodies

Coupling cation and anion exchange chromatography for fast separation of monoclonal antibody charge variants

Multiscale modeling method for therapeutic antibodies in ion exchange chromatography

Ultrasensitive Characterization of Charge Heterogeneity of Therapeutic Monoclonal Antibodies Using Strong Cation Exchange Chromatography Coupled to Native Mass Spectrometry.

The effect of pH on antibody retention in multimodal cation exchange chromatographic systems

A novel method for continuous chromatographic separation of monoclonal antibody charge variants by combining displacement mode chromatography and step elution

Coupling of chromatography and precipitation for adjusting acidic variant content in a monoclonal antibody pool

Targeted CQA analytical control strategy for commercial antibody products: Replacing ion-exchange chromatography methods for charge heterogeneity with multi-attribute monitoring

CE methods for charge variant analysis of mAbs and complex format biotherapeutics

Developing Analytical ion Exchange Chromatography Methods for Antibody Drug Conjugates Containing the Hydrolysis-Prone Succinimide-Thioether Conjugation Chemistry

Characterization of antibody surface properties and selection of a diverse subset for development of a generic size-exclusion chromatography method

Charge variant analysis of monoclonal antibodies by CZE‐MS using a successive multiple ionic‐polymer layer coating based on diethylaminoethyl‐dextran